Ketorolac IV Dosing and Administration
For adult patients, administer ketorolac IV as a 30 mg bolus over at least 15 seconds for patients <65 years, or 15 mg for patients ≥65 years, renally impaired, or <50 kg, with multiple dosing every 6 hours not exceeding 5 days total duration. 1
Single-Dose Regimen
IV Administration:
- Patients <65 years: 30 mg IV bolus
- Patients ≥65 years, renally impaired, or <50 kg: 15 mg IV bolus
- Must be given over no less than 15 seconds 1
- Analgesic effect begins in ~30 minutes, peaks at 1-2 hours, lasts 4-6 hours 1
Multiple-Dose Regimen
For continued pain management:
- Patients <65 years: 30 mg IV every 6 hours (maximum 120 mg/day)
- Patients ≥65 years, renally impaired, or <50 kg: 15 mg IV every 6 hours (maximum 60 mg/day)
- Total duration limit: 5 days maximum (combined IV/IM and oral) 1
IV Drip/Continuous Infusion
Ketorolac is NOT typically given as a continuous IV drip in standard practice. The FDA labeling specifies bolus administration only 1. However, one older study demonstrated that a 30 mg IV bolus followed by 5 mg/hour continuous infusion for 24 hours reduced morphine consumption by 35-44% after orthopedic surgery 2. This approach is not FDA-approved and should only be considered in specialized postoperative settings with appropriate monitoring.
Critical Safety Considerations
Correct hypovolemia BEFORE administering ketorolac 1. The drug carries significant risks:
- GI bleeding risk is dose-dependent and dramatically increases with doses >60 mg/day, especially in elderly patients (7.7% incidence in patients ≥65 years receiving >120 mg/day) 1
- Do NOT mix in syringe with morphine, meperidine, promethazine, or hydroxyzine—causes precipitation 1
- Monitor for renal failure, bleeding complications, and hepatic dysfunction 1
Evidence-Based Dosing Insights
Recent high-quality research challenges traditional dosing. Lower doses (10-15 mg) provide equivalent analgesia to 30 mg in emergency department patients with acute pain 3, 4, 5. A 2023 systematic review found no difference in pain relief between 15-20 mg versus ≥30 mg doses 3. Similarly, a 2021 trial demonstrated that 10 mg, 20 mg, and 30 mg produced identical pain reduction in renal colic 4.
Despite this evidence, the FDA-approved dosing remains 30 mg for standard adult patients 1, and guidelines support using ketorolac as part of multimodal analgesia to reduce opioid consumption 6. The 2018 Critical Care Medicine guidelines suggest using NSAIDs like ketorolac as adjuncts to decrease opioid-related complications 6.
Practical Algorithm
- Assess patient factors: Age, weight, renal function, bleeding risk, volume status
- Correct hypovolemia first if present
- Choose dose:
- Standard adult (<65 years, >50 kg, normal renal function): 30 mg IV
- High-risk patient (≥65 years, <50 kg, or renal impairment): 15 mg IV
- Administer over ≥15 seconds
- If multiple doses needed: Repeat every 6 hours at same dose
- Transition to oral or discontinue by day 5
- Consider lower doses (10-15 mg) for patients at higher risk of adverse events, though this is off-label
Do not increase dose or frequency for breakthrough pain—supplement with low-dose opioids instead 1.